These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3316850)

  • 21. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
    Shivdasani RA; Anderson KC
    Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma].
    García Gala JM; Ramírez Páyer A; Rayón C; Rodríguez Vicente P; Rosón C; Blanco C
    Sangre (Barc); 1993 Dec; 38(6):489-91. PubMed ID: 8171385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
    Hahn T; McCarthy PL; Zhang MJ; Wang D; Arora M; Frangoul H; Gale RP; Hale GA; Horan J; Isola L; Maziarz RT; van Rood JJ; Gupta V; Halter J; Reddy V; Tiberghien P; Litzow M; Anasetti C; Pavletic S; Ringdén O
    J Clin Oncol; 2008 Dec; 26(35):5728-34. PubMed ID: 18981462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.
    Carnevale-Schianca F; Caravelli D; Gallo S; Coha V; D'Ambrosio L; Vassallo E; Fizzotti M; Nesi F; Gioeni L; Berger M; Polo A; Gammaitoni L; Becco P; Giraudo L; Mangioni M; Sangiolo D; Grignani G; Rota-Scalabrini D; Sottile A; Fagioli F; Aglietta M
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):459-466. PubMed ID: 28039079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion-associated chronic cutaneous graft-versus-host disease.
    Hull RJ; Bray RA; Hillyer C; Swerlick RA
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 2):327-32. PubMed ID: 7615879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
    Ahya R; Douglas JG; Watson HG
    Heart; 1998 Sep; 80(3):299-300. PubMed ID: 9875094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor.
    Ryo R; Saigo K; Hashimoto M; Kohsaki M; Yasufuku M; Watanabe N; Okada M; Tadokoro K; Juji T
    Vox Sang; 1999; 76(4):241-6. PubMed ID: 10394145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion associated GVHD.
    Sohi I; Jacob S
    Indian J Pediatr; 2005 Jun; 72(6):533-5. PubMed ID: 15985746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model.
    Dickinson AM; Sviland L; Wang XN; Jackson G; Taylor PR; Dunn A; Proctor SJ
    Transplantation; 1998 Oct; 66(7):857-63. PubMed ID: 9798694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion-associated graft-versus-host disease in a presumably immunocompetent patient after transfusion of stored packed red cells.
    Suzuki K; Akiyama H; Takamoto S; Maruyama Y; Sakamaki H; Akagi K; Maeda Y; Takenaka M; Onozawa Y
    Transfusion; 1992 May; 32(4):358-60. PubMed ID: 1585443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
    Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
    Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfusion-associated acute graft-versus-host disease in a heart transplant recipient.
    Sola MA; España A; Redondo P; Idoate MA; Fernandez AL; Llorens R; Quintanilla E
    Br J Dermatol; 1995 Apr; 132(4):626-30. PubMed ID: 7748758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.
    Messina G; Quartarone E; Console G; Cuzzola M; Iacopino O; Martino M; Irrera G; Morabito F; Iacopino P
    Haematologica; 2002 Jul; 87(7):ECR22. PubMed ID: 12091138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.
    Hutchinson K; Kopko PM; Muto KN; Tuscano J; O'Donnell RT; Holland PV; Richman C; Paglieroni TG; Wun T
    Transfusion; 2002 Dec; 42(12):1567-72. PubMed ID: 12473136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion-associated graft-versus-host disease.
    Orlin JB; Ellis MH
    Curr Opin Hematol; 1997 Nov; 4(6):442-8. PubMed ID: 9359003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfusion-associated graft-versus-host disease in an immunocompetent patient following accidental injury.
    Kobayashi H; Kitano K; Kishi E; Hara K; Ishida F; Saito H; Ota M; Furuta S
    Am J Hematol; 1993 May; 43(1):51-3. PubMed ID: 8317463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
    Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical, nonfatal, transfusion-associated, acute graft-versus-host disease in a patient with Hodgkin's disease.
    Held JL; Druker BJ; Kohn SR; Byrnes W; Margolis RJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):261-2. PubMed ID: 1552066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.